Discovery of SCH446211 (SCH6): A new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication

被引:44
作者
Bogen, SL
Arasappan, A
Bennett, F
Chen, K
Jao, E
Liu, YT
Lovey, RG
Venkatraman, S
Pan, WD
Parekh, T
Pike, RE
Ruan, S
Liu, R
Baroudy, B
Agrawal, S
Chase, R
Ingravallo, P
Pichardo, J
Prongay, A
Brisson, JM
Hsieh, TY
Cheng, KC
Kemp, SJ
Levy, OE
Lim-Wilby, M
Tamura, SY
Saksena, AK
Girijavallabhan, V
Njoroge, FG
机构
[1] Schering Plough Res Inst, Kenilworth, NJ 07033 USA
[2] Dendreon Corp, Seattle, WA 98121 USA
关键词
D O I
10.1021/jm060077j
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Introduction of various modified prolines at P-2 and optimization of the P-1 side chain led to the discovery of SCH6 (24, Table 2), a potent ketoamide inhibitor of the HCV NS3 serine protease. In addition to excellent enzyme potency (K-i* = 3.8 nM), 24 was also found to be a potent inhibitor of HCV subgenomic RNA replication with IC50 and IC90 of 40 and 100 nM, respectively. Recently, antiviral activity of 24 was demonstrated with inhibition of the full-length genotype 2a HCV genome. In addition, 24 was found to restore the responsiveness of the interferon regulatory factor 3 (IRF-3) in cells containing HCV RNA replicons.
引用
收藏
页码:2750 / 2757
页数:8
相关论文
共 32 条
  • [1] The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
    Alter, MJ
    Kruszon-Moran, D
    Nainan, OV
    McQuillan, GM
    Gao, FX
    Moyer, LA
    Kaslow, RA
    Margolis, HS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) : 556 - 562
  • [2] Hepatitis C virus NS3-4A serine protease inhibitors:: SAR of P′2 moiety with improved potency
    Arasappan, A
    Njoroge, FG
    Chan, TY
    Bennett, F
    Bogen, SL
    Chen, K
    Gu, H
    Hong, L
    Jao, E
    Liu, YT
    Lovey, RG
    Parekh, T
    Pike, RE
    Pinto, P
    Santhanam, B
    Venkatraman, S
    Vaccaro, H
    Wang, H
    Yang, X
    Zhu, Z
    Mckittrick, B
    Saksena, AK
    Girijavallabhan, V
    Pichardo, J
    Butkiewicz, N
    Ingram, R
    Malcolm, B
    Prongay, A
    Yao, N
    Marten, B
    Madison, V
    Kemp, S
    Levy, O
    Lim-Wilby, M
    Tamura, S
    Gangulya, AK
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (19) : 4180 - 4184
  • [3] Novel 2-oxoimidazolidine-4-carboxylic acid derivatives as Hepatitis C virus NS3-4A serine protease inhibitors: synthesis, activity, and X-ray crystal structure of an enzyme inhibitor complex
    Arasappan, A
    Njoroge, FG
    Parekh, TN
    Yang, XZ
    Pichardo, J
    Butkiewicz, N
    Prongay, A
    Yao, NH
    Girijavallabhan, V
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (23) : 5751 - 5755
  • [4] Replication of hepatitis C virus
    Bartenschlager, R
    Lohmann, V
    [J]. JOURNAL OF GENERAL VIROLOGY, 2000, 81 : 1631 - 1648
  • [5] The identification of α-ketoamides as potent inhibitors of hepatitis C virus NS3-4A proteinase
    Bennett, JM
    Campbell, AD
    Campbell, AJ
    Carr, MG
    Dunsdon, RM
    Greening, JR
    Hurst, DN
    Jennings, NS
    Jones, PS
    Jordan, S
    Kay, PB
    O'Brien, MA
    King-Underwood, J
    Raynham, TM
    Wilkinson, CS
    Wilkinson, TCI
    Wilson, FX
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (03) : 355 - 357
  • [6] Hepatitis C virus NS3-4A serine protease inhibitors:: Use of a P2-P1 cyclopropyl alanine combination for improved potency
    Bogen, S
    Saksena, AK
    Arasappan, A
    Gu, H
    Njoroge, FG
    Girijavallabhan, V
    Pichardo, J
    Butkiewicz, N
    Prongay, A
    Madison, V
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) : 4515 - 4519
  • [7] Depeptidization efforts on P3-P′2 α-ketoamide inhibitors of HCVNS3-4A serine protease:: Effect on HCV replicon activity
    Bogen, SL
    Ruan, S
    Liu, R
    Agrawal, S
    Pichardo, J
    Prongay, A
    Baroudy, B
    Saksena, AK
    Girijavallabhan, V
    Njoroge, FG
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (06) : 1621 - 1627
  • [8] Design, synthesis, and biological activity of m-tyrosine-based 16-and 17-membered macrocyclic inhibitors of hepatitis C virus NS3 serine protease
    Chen, KX
    Njoroge, FG
    Pichardo, J
    Prongay, A
    Butkiewicz, N
    Yao, NH
    Madison, V
    Girijavallabhan, V
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (20) : 6229 - 6235
  • [9] CHEN M, Patent No. 2004113272
  • [10] The scientific challenge of hepatitis C
    Cohen, J
    [J]. SCIENCE, 1999, 285 (5424) : 26 - 30